STRATA Skin Sciences, Inc. (SSKN)
0.245
-0.03
(-12.47%)
USD |
OTCM |
Mar 25, 14:43
STRATA Skin Sciences Cash from Investing (Quarterly) : -1.018M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| AtriCure, Inc. | -2.602M |
| Intuitive Surgical, Inc. | -209.40M |
| Abbott Laboratories | -913.00M |
| Accuray, Inc. | -5.596M |
| Plus Therapeutics, Inc. | -1.077M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.064M |
| Cash from Financing (Quarterly) | 2.192M |
| Free Cash Flow | -3.512M |
| Free Cash Flow Per Share (Quarterly) | -0.2414 |
| Free Cash Flow to Equity (Quarterly) | -1.041M |
| Free Cash Flow to Firm (Quarterly) | -0.584M |
| Free Cash Flow Yield | -337.4% |